Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy | |
Wang, Yue-shen; Tian, Jing; Han, Yong; Han, Shu-mei; Shi, Sheng-bin | |
刊名 | ONCOLOGY RESEARCH |
2016 | |
卷号 | 24期号:2页码:129-135 |
关键词 | Advanced esophageal cancer Second-line treatment Gemcitabine plus vinorelbine Platinum-based chemotherapy miRNA-214 Progression-free survival |
DOI | 10.3727/096504016X14618564639213 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4695197 |
专题 | 山东大学 |
作者单位 | 1.Jilin Peoples Hosp, Dept Oncol, Jilin, Jilin, Peoples R China. 2.Shandong Univ |
推荐引用方式 GB/T 7714 | Wang, Yue-shen,Tian, Jing,Han, Yong,et al. Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy[J]. ONCOLOGY RESEARCH,2016,24(2):129-135. |
APA | Wang, Yue-shen,Tian, Jing,Han, Yong,Han, Shu-mei,&Shi, Sheng-bin.(2016).Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy.ONCOLOGY RESEARCH,24(2),129-135. |
MLA | Wang, Yue-shen,et al."Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy".ONCOLOGY RESEARCH 24.2(2016):129-135. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论